4//SEC Filing
FLUKE JOHN M JR 4
Accession 0001209191-21-007925
CIK 0001620463other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 8:18 PM ET
Size
11.7 KB
Accession
0001209191-21-007925
Insider Transaction Report
Form 4
FLUKE JOHN M JR
Director
Transactions
- Exercise/Conversion
Common Stock
2021-02-03$1.19/sh+25,220$30,012→ 140,101 total - Exercise/Conversion
Common Stock
2021-02-03$1.35/sh+3,783$5,107→ 143,884 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-03−25,220→ 0 totalExercise: $1.19Exp: 2027-12-12→ Common Stock (25,220 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2021-02-03−3,783→ 0 totalExercise: $1.35Exp: 2030-01-28→ Common Stock (3,783 underlying)
Holdings
- 6,731(indirect: By Fluke Capital Management, L.P.)
Common Stock
Footnotes (3)
- [F1]This filing relates to the exercise of stock options. No shares of Common Stock were sold by Mr. Fluke, and the shares of Common Stock received upon exercise of the stock options are subject to lock-up agreements with Goldman Sachs & Co. LLC and Jefferies LLC.
- [F2]The shares subject to the option fully vested on December 13, 2020.
- [F3]The shares subject to the option fully vested on December 13, 2019.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001191906
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 8:18 PM ET
- Size
- 11.7 KB